Mutamycin Powder For Solution For Injection 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mutamycin: Powder for solution for injection (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MITOMYCIN (mye toe MYE sin) is a chemotherapy drug. This medicine is used to treat cancer of the stomach and pancreas.

In-Depth Information

Mutamycin 20mg Powder for Injection

NDC: 000153002
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Gastric Cancer, Pancreatic Cancer

Sometimes used for but not FDA approved for the following conditions:
Colorectal Cancer, Cervical Cancer, Biliary Tract Cancer, Anal Cancer, Mesothelioma, Head And Neck Cancer, Bladder Cancer

Storage Information
Reconstituted product may be stored for up to 14 days if refrigerated (36 to 46 degrees F)
Store unreconstituted product at room temperature (77 degrees F), excursions of 59 to 86 degrees F permitted
Avoid excessive heat (above 104 degrees F)
Mutamycin 20mg Powder for Injection

Reported Side Effects for Mutamycin 20mg Powder for Injection

Irritated Blood Vessels Incidence:
>4.0%*
Severity: MODERATE
Onset: RAPID
Decreased Appetite Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Pancytopenia Incidence:
>10.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mutamycin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5